CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 23, 2013--
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the Deutsche Bank 38th Annual Healthcare Conference being
held in Boston. Harvey J. Berger, M.D., chairman and chief executive
officer, will provide an overview of the Company’s business on Thursday,
May 30, 2013 at 10:00 a.m. (ET).
The ARIAD presentation will be webcast live and can be accessed by
visiting the investor relations section of the Company's website at http://www.ariad.com/investor.
A replay of the presentation will also be available and archived on the
site for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts
and Lausanne, Switzerland, is an integrated global oncology company
focused on transforming the lives of cancer patients with breakthrough
medicines. ARIAD is working on new medicines to advance the treatment of
various forms of chronic and acute leukemia, lung cancer and other
difficult-to-treat cancers. ARIAD utilizes computational and structural
approaches to design small-molecule drugs that overcome resistance to
existing cancer medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
Source: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
Liza Heapes, 617-621-2315